v1
Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
Identifier:nobleid.org/w1/20260515/496EECB8
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/496EECB8)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims